Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients.

Philipp Spring Zoi Spanou Pierre A de Viragh

J Am Acad Dermatol

Dermatology University Clinic, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; Dermatology University Clinic, Inselspital, Bern, Switzerland; Private practice, Zurich, Switzerland. Electronic address:

Published: November 2013

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2013.04.066	DOI Listing

Publication Analysis

Top Keywords

lichen planopilaris

planopilaris treated

treated peroxisome

peroxisome proliferator

proliferator activated

activated receptor-γ

receptor-γ agonist

agonist pioglitazone

pioglitazone lack

lack lasting

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!